MTOR and diabetes mellitus: Our unexpected discovery of the non-overlap impact of AMPK and mTOR signaling in the upper small intestine raises the possibility that targeting the mTOR-dependent pathway in the small intestine represents a unique strategy to lower glucose levels in diabetes.